{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:04:01Z","timestamp":1789340641840,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ITMO Cancer AVIESAN"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48222-x","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:53:26Z","timestamp":1782096806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Aur\u00e9lie","family":"Bocquier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00efa","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gagneux-Brunon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Gauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Le Duc-Banaszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Thilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PrevHPV Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bonnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ecollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselin","family":"Le Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Partouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Pinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Tron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos-Paul","family":"Hagiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Juneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ailloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Branchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Jeanleboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Jambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Botelho-Nevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabrouk","family":"Nekaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Chevreul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Team 7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Raude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sicsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Barret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Chyderiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Oudin-Doglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josee","family":"Dussault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Other","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Castagnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Simony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"48222_CR1","unstructured":"World Health Organization. Human papillomavirus and cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer (2024)."},{"key":"48222_CR2","first-page":"CD013479","volume":"11","author":"H Bergman","year":"2019","unstructured":"Bergman, H. et al. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database Syst. Rev. 11, CD013479 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"48222_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet, M. et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 394, 497\u2013509 (2019).","journal-title":"Lancet"},{"key":"48222_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399","volume":"144","author":"L Bruni","year":"2021","unstructured":"Bruni, L. et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019. Prev. Med. 144, 106399 (2021).","journal-title":"Prev. Med."},{"key":"48222_CR5","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.vaccine.2019.11.081","volume":"38","author":"N-H Nguyen-Huu","year":"2020","unstructured":"Nguyen-Huu, N.-H. et al. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine 38, 1315\u20131331 (2020).","journal-title":"Vaccine"},{"key":"48222_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1186\/1471-2458-14-700","volume":"14","author":"HB Ferrer","year":"2014","unstructured":"Ferrer, H. B., Trotter, C., Hickman, M. & Audrey, S. Barriers and facilitators to HPV vaccination of young women in high-income countries: A qualitative systematic review and evidence synthesis. BMC Public Health 14, 700 (2014).","journal-title":"BMC Public Health"},{"key":"48222_CR7","doi-asserted-by":"publisher","first-page":"2016304","DOI":"10.1080\/21645515.2021.2016304","volume":"18","author":"SR Newcomer","year":"2022","unstructured":"Newcomer, S. R. et al. Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state. Hum. Vaccin. Immunother. 18, 2016304 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"48222_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s12889-024-18206-5","volume":"24","author":"S Xiong","year":"2024","unstructured":"Xiong, S. et al. Associations of geographic-based socioeconomic factors and HPV vaccination among male and female children in five US states. BMC Public Health 24, 702 (2024).","journal-title":"BMC Public Health"},{"key":"48222_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.vaccine.2021.12.003","volume":"40","author":"S Kurani","year":"2022","unstructured":"Kurani, S. et al. Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake. Vaccine 40, 471\u2013476 (2022).","journal-title":"Vaccine"},{"key":"48222_CR10","first-page":"441","volume":"22","author":"C Blondel","year":"2019","unstructured":"Blondel, C. et al. Influence des facteurs socio\u00e9conomiques sur la vaccination contre les infections \u00e0 HPV chez les adolescentes en France. Bull. Epid\u00e9miol. Hebd. 22, 441\u2013450 (2019).","journal-title":"Bull. Epid\u00e9miol. Hebd."},{"key":"48222_CR11","first-page":"424","volume":"22\u201323","author":"L Fonteneau","year":"2019","unstructured":"Fonteneau, L., Barret, A. S. & L\u00e9vy-Bruhl, D. Evolution de la couverture vaccinale du vaccin contre le papillomavirus en France\u20142008\u20132018. Bull. Epid\u00e9miol. Hebd. 22\u201323, 424\u2013430 (2019).","journal-title":"Bull. Epid\u00e9miol. Hebd."},{"key":"48222_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/hex.13778","volume":"26","author":"A Bocquier","year":"2023","unstructured":"Bocquier, A. et al. Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study). Health Expect. 26, 1843\u20131853 (2023).","journal-title":"Health Expect."},{"key":"48222_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057943","volume":"12","author":"A Bocquier","year":"2022","unstructured":"Bocquier, A. et al. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). BMJ Open 12, e057943 (2022).","journal-title":"BMJ Open"},{"key":"48222_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13690-023-01227-8","volume":"82","author":"A Tron","year":"2024","unstructured":"Tron, A. et al. Barriers and facilitators to the HPV vaccine: A multicenter qualitative study of French general practitioners. Arch. Public Health 82, 2 (2024).","journal-title":"Arch. Public Health"},{"key":"48222_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12889-023-15342-2","volume":"23","author":"A Bocquier","year":"2023","unstructured":"Bocquier, A. et al. Promoting HPV vaccination at school: A mixed methods study exploring knowledge, beliefs and attitudes of French school staff. BMC Public Health 23, 486 (2023).","journal-title":"BMC Public Health"},{"key":"48222_CR16","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.vaccine.2021.05.061","volume":"39","author":"S Chyderiotis","year":"2021","unstructured":"Chyderiotis, S. et al. Optimising HPV vaccination communication to adolescents: A discrete choice experiment. Vaccine 39, 3916\u20133925 (2021).","journal-title":"Vaccine"},{"key":"48222_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.11938","volume":"7","author":"N Thilly","year":"2024","unstructured":"Thilly, N. et al. Effectiveness of a school- and primary care-based HPV vaccination intervention: The PrevHPV cluster randomized trial. JAMA Netw. Open 7, e2411938 (2024).","journal-title":"JAMA Netw. Open"},{"key":"48222_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102931","volume":"18","author":"A Bocquier","year":"2025","unstructured":"Bocquier, A. et al. Implementation evaluation of a school- and primary care-based multicomponent intervention to improve HPV vaccine coverage: Results from the PrevHPV randomized controlled trial. J. Infect. Public Health 18, 102931 (2025).","journal-title":"J. Infect. Public Health"},{"key":"48222_CR19","volume-title":"Les Comportements de Sant\u00e9 Des Jeunes : Analyses Du Barom\u00e8tre Sant\u00e9 2010","author":"F Beck","year":"2013","unstructured":"Beck, F. & Richard, J. B. Les Comportements de Sant\u00e9 Des Jeunes\u202f: Analyses Du Barom\u00e8tre Sant\u00e9 2010 (Inpes, 2013)."},{"key":"48222_CR20","doi-asserted-by":"publisher","first-page":"BJGPO.2024.0290","DOI":"10.3399\/BJGPO.2024.0290","volume":"9","author":"E Million","year":"2025","unstructured":"Million, E. et al. The strange adolescent world that complicates general practitioner prevention: A qualitative study. BJGP Open 9, BJGPO.2024.0290 (2025).","journal-title":"BJGP Open"},{"key":"48222_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12875-025-02910-1","volume":"26","author":"D-P Hagiu","year":"2025","unstructured":"Hagiu, D.-P. et al. Co-designing a shared digital decision aid for HPV vaccination in French general practice. BMC Prim Care 26, 215 (2025).","journal-title":"BMC Prim Care"},{"key":"48222_CR22","unstructured":"Sant\u00e9 publique France. Donn\u00e9es de couverture vaccinale papillomavirus humains (HPV) par groupe d\u2019\u00e2ge. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/articles\/donnees-de-couverture-vaccinale-papillomavirus-humains-hpv-par-groupe-d-age (2025)."},{"key":"48222_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.therap.2023.01.009","volume":"78","author":"S De Germay","year":"2023","unstructured":"De Germay, S. et al. Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice. Therapies 78, 679\u2013689 (2023).","journal-title":"Therapies"},{"key":"48222_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2458-9-33","volume":"9","author":"G Rey","year":"2009","unstructured":"Rey, G., Jougla, E., Fouillet, A. & H\u00e9mon, D. Ecological association between a deprivation index and mortality in France over the period 1997\u20132001: Variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health 9, 33 (2009).","journal-title":"BMC Public Health"},{"key":"48222_CR25","unstructured":"Direction de la recherche, des \u00e9tudes, de l\u2019evaluation et des statistiques (DREES). L\u2019accessibilit\u00e9 potentielle localis\u00e9e (APL): une nouvelle mesure de l\u2019accessibilit\u00e9 aux m\u00e9decins g\u00e9n\u00e9ralistes lib\u00e9raux en France. (2012)."},{"key":"48222_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell, S. et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ 389, e081123 (2025).","journal-title":"BMJ"},{"key":"48222_CR27","doi-asserted-by":"crossref","unstructured":"Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & CONSORT Group. Consort 2010 statement: Extension to cluster randomised trials. BMJ 345, e5661 (2012).","DOI":"10.1136\/bmj.e5661"},{"key":"48222_CR28","doi-asserted-by":"publisher","first-page":"2319426","DOI":"10.1080\/21645515.2024.2319426","volume":"20","author":"M Felsher","year":"2024","unstructured":"Felsher, M. et al. A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs. Hum. Vaccin. Immunother. 20, 2319426 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"key":"48222_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103290","volume":"84","author":"J Han","year":"2025","unstructured":"Han, J. et al. Global HPV vaccination programs and coverage rates: A systematic review. EClinicalMedicine 84, 103290 (2025).","journal-title":"EClinicalMedicine"},{"key":"48222_CR30","doi-asserted-by":"crossref","unstructured":"L\u00e9vy-Bruhl, D. [Successes and failures of anti-HBV vaccination in France: historical background and questions for research]. Rev Epidemiol Sante Publique 54 Spec No 1, 1S89\u201381S94 (2006).","DOI":"10.1016\/S0398-7620(06)76768-2"},{"key":"48222_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ebiom.2016.08.042","volume":"12","author":"HJ Larson","year":"2016","unstructured":"Larson, H. J. et al. The state of vaccine confidence 2016: Global insights through a 67-country survey. EBioMedicine 12, 295\u2013301 (2016).","journal-title":"EBioMedicine"},{"key":"48222_CR32","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1016\/j.vaccine.2019.07.061","volume":"37","author":"T Chantler","year":"2019","unstructured":"Chantler, T. et al. Optimising informed consent in school-based adolescent vaccination programmes in England: A multiple methods analysis. Vaccine 37, 5218\u20135224 (2019).","journal-title":"Vaccine"},{"key":"48222_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2023.107542","volume":"172","author":"C Davies","year":"2023","unstructured":"Davies, C. et al. Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial. Prev. Med. 172, 107542 (2023).","journal-title":"Prev. Med."},{"key":"48222_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102931","volume":"48","author":"M Dionne","year":"2024","unstructured":"Dionne, M., Sauvageau, C., Etienne, D., Witteman, H. O. & Dub\u00e9, \u00c8. Feasibility of interventions to increase HPV vaccination acceptability and coverage in school-based programs: Findings from a pilot study in Quebec, Canada. Prev. Med. Rep. 48, 102931 (2024).","journal-title":"Prev. Med. Rep."},{"key":"48222_CR35","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1080\/21645515.2018.1564440","volume":"15","author":"E Dub\u00e9","year":"2019","unstructured":"Dub\u00e9, E. et al. Challenges and opportunities of school-based HPV vaccination in Canada. Hum. Vaccin. Immunother. 15, 1650\u20131655 (2019).","journal-title":"Hum. Vaccin. Immunother."},{"key":"48222_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12889-017-4168-0","volume":"17","author":"S Perman","year":"2017","unstructured":"Perman, S. et al. School-based vaccination programmes: A systematic review of the evidence on organisation and delivery in high income countries. BMC Public Health 17, 252 (2017).","journal-title":"BMC Public Health"},{"key":"48222_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048017","volume":"7","author":"RM Bartolini","year":"2012","unstructured":"Bartolini, R. M., Winkler, J. L., Penny, M. E. & LaMontagne, D. S. Parental acceptance of HPV vaccine in Peru: A decision framework. PLoS ONE 7, e48017 (2012).","journal-title":"PLoS ONE"},{"key":"48222_CR38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/hea0001387","volume":"43","author":"D Oudin Doglioni","year":"2024","unstructured":"Oudin Doglioni, D. et al. Shared human papillomavirus vaccine readiness within families: A psychometric analysis of parent-adolescent dyads in France. Health Psychol. 43, 893\u2013903 (2024).","journal-title":"Health Psychol."},{"key":"48222_CR39","unstructured":"Gouvernement. Campagne de vaccination gratuite contre les papillomavirus dans les coll\u00e8ges. (2023)."},{"key":"48222_CR40","doi-asserted-by":"crossref","unstructured":"de Klerk, C. M., Gupta, S., Dekker, E., Essink-Bot, M. L. & Expert Working Group \u2018Coalition to reduce inequities in colorectal cancer screening\u2019 of the World Endoscopy Organization. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide. Gut 67, 679\u2013687 (2018).","DOI":"10.1136\/gutjnl-2016-313311"},{"key":"48222_CR41","unstructured":"Centers for Disease Control and Prevention (CDC). Breast cancer screening and socioeconomic status--35 metropolitan areas, 2000 and 2002. MMWR Morb Mortal Wkly Rep 54, 981\u2013985 (2005)."},{"key":"48222_CR42","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1016\/j.vaccine.2021.08.096","volume":"39","author":"E Karafillakis","year":"2021","unstructured":"Karafillakis, E., Peretti-Watel, P., Verger, P., Chantler, T. & Larson, H. J. The role of maturity in adolescent decision-making around HPV vaccination in France. Vaccine 39, 5741\u20135747 (2021).","journal-title":"Vaccine"},{"key":"48222_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-001007","volume":"3","author":"J Dussault","year":"2025","unstructured":"Dussault, J. et al. Effect of a multicomponent HPV intervention on self-reported HPV vaccine uptake and intention among French adolescents and parents: results from the national, cluster-randomised PrevHPV trial. BMJ Public Health 3, e001007 (2025).","journal-title":"BMJ Public Health"},{"key":"48222_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127344","volume":"61","author":"JM Dussault","year":"2025","unstructured":"Dussault, J. M. et al. The effect of school-based interventions on HPV vaccine-related knowledge, attitudes, and practices among adolescents in France: Secondary results from the PrevHPV trial. Vaccine 61, 127344 (2025).","journal-title":"Vaccine"},{"key":"48222_CR45","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40271-024-00687-6","volume":"17","author":"S Chyderiotis","year":"2024","unstructured":"Chyderiotis, S. et al. Optimizing communication on HPV vaccination to parents of 11- to 14-year-old adolescents in France: A discrete choice experiment. Patient 17, 575\u2013588 (2024).","journal-title":"Patient"},{"key":"48222_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jamaoncol.2015.3924","volume":"2","author":"JM Unger","year":"2016","unstructured":"Unger, J. M., Gralow, J. R., Albain, K. S., Ramsey, S. D. & Hershman, D. L. Patient income level and cancer clinical trial participation: A prospective survey study. JAMA Oncol. 2, 137\u2013139 (2016).","journal-title":"JAMA Oncol."},{"key":"48222_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/03630242.2024.2334700","volume":"64","author":"A Cardenas-Rojas","year":"2024","unstructured":"Cardenas-Rojas, A. et al. Factors influencing clinical trial participation of women with fibromyalgia across the United States: A cross-sectional survey. Women Health 64, 369\u2013379 (2024).","journal-title":"Women Health"},{"key":"48222_CR48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jme.2006.017681","volume":"33","author":"CC Denny","year":"2007","unstructured":"Denny, C. C. & Grady, C. Clinical research with economically disadvantaged populations. J. Med. Ethics 33, 382\u2013385 (2007).","journal-title":"J. Med. Ethics"},{"key":"48222_CR49","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12913-024-11129-2","volume":"24","author":"A Bourgeois","year":"2024","unstructured":"Bourgeois, A. et al. Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: A scoping review. BMC Health Serv. Res. 24, 670 (2024).","journal-title":"BMC Health Serv. Res."},{"key":"48222_CR50","doi-asserted-by":"publisher","first-page":"30406","DOI":"10.2807\/1560-7917.ES.2016.21.47.30406","volume":"21","author":"P Verger","year":"2016","unstructured":"Verger, P. et al. Prevalence and correlates of vaccine hesitancy among general practitioners: A cross-sectional telephone survey in France, April to July 2014. Euro Surveill. 21, 30406 (2016).","journal-title":"Euro Surveill."},{"key":"48222_CR51","unstructured":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9. Calendrier des vaccinations et recommandations vaccinales 2021. (2021)."},{"key":"48222_CR52","doi-asserted-by":"publisher","first-page":"1033486","DOI":"10.3389\/fmed.2022.1033486","volume":"9","author":"C Berkhout","year":"2022","unstructured":"Berkhout, C. et al. Defining and evaluating the Hawthorne effect in primary care, a systematic review and meta-analysis. Front. Med. 9, 1033486 (2022).","journal-title":"Front. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48222-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48222-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48222-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T22:49:10Z","timestamp":1789339750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48222-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48222"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48222-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Pr AGB reported receiving honoraria from MSD, Moderna, and Pfizer paid to her institution and financial support for attending meetings and\/or travel from MSD and Moderna, all outside the submitted work. Pr AG reported receiving honoraria from MSD paid to her institution and financial support for attending meetings and\/or travel from MSD, all outside the submitted work. No other disclosures were reported.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28527"}}